Inventor · disambiguated record
Bharat Majeti
Also filed as: MAJETI BHARAT · MAJETI BHARAT KUMAR
13 granted patents·9 pending applications·34 citations·filing 2007–2025
89Inventor score
Top patents by PatentIndex Score
22 records- 0195US9771582B2RNA interference compositions and methods for malignant tumorsNITTO DENKO CORP·Filed 2015·Granted Sep 26, 2017·13 cites·35 claims
- 0292USRE48887ERNA interference compositions and methods for malignant tumorsNITTO DENKO CORP·Filed 2019·Granted Jan 11, 2022·2 cites·35 claims
- 0392US9580710B2Methods and compositions for treating malignant tumors associated with KRAS mutationNITTO DENKO CORP·Filed 2015·Granted Feb 28, 2017·7 cites·27 claims
- 0488US10167253B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2016·Granted Jan 1, 2019·6 cites·16 claims
- 0586US11384051B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2018·Granted Jul 12, 2022·2 cites·14 claims
- 0686US10792299B2Methods and compositions for treating malignant tumors associated with kras mutationNITTO DENKO CORP·Filed 2017·Granted Oct 6, 2020·3 cites·19 claims
- 0782US11413243B2Fusogenic compounds for delivery of biologically active moleculesNITTO DENKO CORP·Filed 2018·Granted Aug 16, 2022·1 cites·23 claims
- 0880US2022087531A1Rna interference compositions and methods for malignant tumorsNITTO DENKO CORP·Filed 2021·Application pending·0 cites
- 0979US12319643B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2022·Granted Jun 3, 2025·0 cites·12 claims
- 1077US2025250226A1Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2025·Application pending·0 cites
- 1176US12440445B2Fusogenic compounds for delivery of biologically active moleculesNITTO DENKO CORP·Filed 2022·Granted Oct 14, 2025·0 cites·11 claims
- 1274USRE49229EMethods and compositions for treating malignant tumors associated with KRAS mutationNITTO DENKO CORP·Filed 2020·Granted Oct 4, 2022·0 cites·27 claims
- 1371US2024141342A1Rna interference delivery formulation and methods for malignant tumorsNITTO DENKO CORP·Filed 2023·Application pending·0 cites
- 1466US11708575B2RNA interference delivery formulation and methods for malignant tumorsNITTO DENKO CORP·Filed 2019·Granted Jul 25, 2023·0 cites·17 claims
- 1566US11352628B2Methods and compositions for treating malignant tumors associated with KRAS mutationNITTO DENKO CORP·Filed 2019·Granted Jun 7, 2022·0 cites·20 claims
- 1663US2017218365A1Methods for malignant tumors with rnai molecules targeted to hsp47NITTO DENKO CORP·Filed 2017·Application pending·0 cites
- 1760US2022275373A1Methods and compositions for treating malignant tumors associated with kras mutationNITTO DENKO CORP·Filed 2022·Application pending·0 cites
- 1856US2018002702A1Methods and compositions for treating malignant tumors associated with kras mutationNITTO DENKO CORP·Filed 2017·Application pending·0 cites
- 1955US2022049251A1dsRNA Directed to Coronavirus ProteinsNITTO DENKO CORP·Filed 2021·Application pending·0 cites
- 2046US9403869B2α5β1 integrin binding RGD-lipopeptides with gene transfer activitiesMAJETI BHARAT KUMAR·Filed 2007·Granted Aug 2, 2016·0 cites·13 claims
- 2140US2012021036A1Composite nanostructures and methods for making and using themMAJETI BHARAT·Filed 2010·Application pending·0 cites
- 2236US2018235995A1Rna interference therapeutics against ebola virusYING WENBIN·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bharat Majeti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →